Life Sciences
Foley’s Life Sciences Industry Team is composed of corporate, health care, regulatory, and IP attorneys, whose 360º approach helps address your immediate, specific legal issues, while our deep industry knowledge enables us to work with your long-term objectives in mind.
From fluctuating global financial markets and a rapidly changing IP environment to regulatory hurdles that can affect the products you bring to market, the life sciences industry poses challenges to start-ups and established enterprises alike. For more than 25 years, we have been partnering with life sciences companies like yours at all stages of development to help them make their mark on the industry. The cornerstone of our success is our ability to blend both technical and legal insight on the most complex life sciences innovation.
Contacts
Related Services
Insights
Vaping Will Not Make You Well
23 December 2021
Health Care Law Today
The Proposed Cures 2.0 Act – What You Can Expect
06 December 2021
Health Care Law Today
The Export Import Bank of the United States: Priorities and Programs Supporting U.S. Businesses and Jobs
04 May 2021
Manufacturing Industry Advisor
Round Two - FDA Issues Emergency Use Authorization for Moderna’s COVID-19 Vaccine
21 December 2020
Coronavirus Resource Center:Back to Business
Foley Represents TCGX in $200M Private Placement Financing for Inhibrx
06 September 2023
Foley Attorneys Recognized in 2023 Best Lawyers in America
18 August 2022
American Intellectual Property Law Association (AIPLA) 2021 Annual Meeting
28 October 2021
National Harbor, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream
Delivery of Cell, RNA and DNA Therapeutics | Surveying the Business and IP Landscape
18 May 2021
Webinar
Contracting in the Data-Driven World: Strategies for Handling IP and Personal Data
14 April 2021
Webinar